Myocardin-related transcription factor A (MRTF-A) contributes to acute kidney injury by regulating macrophage ROS production

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3109-3121. doi: 10.1016/j.bbadis.2018.05.026. Epub 2018 Jun 14.

Abstract

A host of pathogenic factors induce acute kidney injury (AKI) leading to insufficiencies of renal function. In the present study we evaluated the role of myocardin-related transcription factor A (MRTF-A) in the pathogenesis of AKI. We report that systemic deletion of MRTF-A or inhibition of MRTF-A activity with CCG-1423 significantly attenuated AKI in mice induced by either ischemia-reperfusion or LPS injection. Of note, MRTF-A deficiency or suppression resulted in diminished renal ROS production in AKI models with down-regulation of NAPDH oxdiase 1 (NOX1) and NOX4 expression. In cultured macrophages, MRTF-A promoted NOX1 transcription in response to either hypoxia-reoxygenation or LPS treatment. Interestingly, macrophage-specific MRTF-A deletion ameliorated AKI in mice. Mechanistic analyses revealed that MRTF-A played a role in regulating histone H4K16 acetylation surrounding the NOX gene promoters by interacting with the acetyltransferase MYST1. MYST1 depletion repressed NOX transcription in macrophages. Finally, administration of a MYST1 inhibitor MG149 alleviated AKI in mice. Therefore, we data illustrate a novel epigenetic pathway that controls ROS production in macrophages contributing to AKI. Targeting the MRTF-A-MYST1-NOX axis may yield novel therapeutic strategies to combat AKI.

Keywords: Acute kidney injury; Epigenetics; Macrophage; ROS; Transcriptional regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Acute Kidney Injury / drug therapy
  • Acute Kidney Injury / genetics*
  • Acute Kidney Injury / metabolism
  • Anilides / pharmacology
  • Animals
  • Benzamides / pharmacology
  • Cells, Cultured
  • Disease Models, Animal
  • Gene Deletion
  • Histone Acetyltransferases / antagonists & inhibitors
  • Histone Acetyltransferases / metabolism*
  • Histones / metabolism
  • Lipopolysaccharides / adverse effects
  • Macrophages / cytology
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Mice
  • NADPH Oxidase 1 / genetics*
  • NADPH Oxidase 1 / metabolism
  • NADPH Oxidase 4 / genetics*
  • NADPH Oxidase 4 / metabolism
  • Promoter Regions, Genetic
  • Reactive Oxygen Species / metabolism
  • Salicylates / administration & dosage
  • Salicylates / pharmacology
  • Trans-Activators / genetics*

Substances

  • 2-(2-(4-heptylphenyl)ethyl)-6-hydroxy-benzoic acid
  • Anilides
  • Benzamides
  • CCG 1423
  • Histones
  • Lipopolysaccharides
  • Mrtfa protein, mouse
  • Reactive Oxygen Species
  • Salicylates
  • Trans-Activators
  • NADPH Oxidase 1
  • NADPH Oxidase 4
  • NOX1 protein, mouse
  • Nox4 protein, mouse
  • Histone Acetyltransferases